Related Articles
Alteration of CDKN2/p16 in human astrocytic tumors is related with increased susceptibility to antimetabolite anticancer agents.
Heterogeneity of tumor chemosensitivity in ovarian epithelial cancer revealed using the adenosine triphosphate-tumor chemosensitivity assay
Histoculture drug response assay predicts the postoperative prognosis of patients with esophageal cancer
Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas
Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells